Numbing Medicine for Pain After Chest Surgery
Treatments studied
Part of Brain & nervous system, Pain clinical trials.
This trial is testing whether a numbing medicine called bupivacaine, given into the chest space during surgery, can reduce pain after minimally invasive chest surgery. It aims to find a better way to manage pain after the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a minimally invasive chest surgery (video-assisted thoracoscopic surgery).
- You are 18 years old or older.
- Your overall health is rated as ASA Class I, II, or III (healthy to moderately sick).
- You are not pregnant or breastfeeding.
- You have no history of chronic pain, alcohol or opioid dependence, significant heart or lung issues, central nervous system disorders, liver or kidney problems, or allergies to the numbing medicines used.
- You do not have an infection where the numbing medicine would be given, and you are able to communicate easily with the medical team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a numbing medicine (liposomal bupivacaine) injected near the ribs can reduce pain after lung surgery. If you qualify, you may experience less pain and need fewer painkillers after your operation.
This trial tests if a long-acting numbing medicine called liposomal bupivacaine can reduce pain after video-assisted lung surgery. It aims to help patients feel better after the procedure with less need for other painkillers.
This study compares two types of numbing medicine (liposomal vs. hydrochloride bupivacaine) injected near the ribs during lung surgery. The goal is to see which one provides better pain relief after the operation.
This early-stage trial tests whether a numbing medication (bupivacaine) delivered through a chest tube after heart bypass surgery can safely reduce pain. If it works, it could help heart surgery patients recover more comfortably without as much strong pain medication.
This trial tests whether a long-lasting numbing shot (liposomal bupivacaine) works better than a regular numbing shot (plain bupivacaine) for pain after minimally invasive chest surgery. It may help you have less post-surgery pain and potentially use less pain medication.
This study tests whether a long-lasting numbing medicine (liposomal bupivacaine) injected near the spine can better control pain after lung surgery. It compares this to a standard numbing medicine, and aims to help patients recover with less pain after surgery.
Hear when a new Pain Management trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.